IRIS International, Amerinet announce new supply agreement

NewsGuard 100/100 Score

IRIS International, Inc. (Nasdaq:IRIS) a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, today announced a new supply agreement for its full product line of automated and semi-automated urinalysis systems, related products, consumables and services agreements, with Amerinet Inc., a leading national healthcare group purchasing organization (GPO) servicing more than 41,000 provider facilities, including 2,537 acute care hospitals. The new three-year sales and service supply agreement went into effect June 1, 2010.

"We are pleased to renew our supply agreement with Amerinet, one of the largest GPOs in the country. Since beginning our partnership with Amerinet in June 2007, the installed base of IRIS instrumentation within the Amerinet membership has grown by more than 400%, representing a vital sales channel for our urinalysis systems and consumables," stated Thomas E. Warekois, President of the Iris Diagnostics Division.   "We look forward to continuing our strong strategic partnership with Amerinet in the years ahead, and to bringing laboratory automation to an increasing number of its members," he added.

SOURCE IRIS International, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.